191 related articles for article (PubMed ID: 7822018)
1. Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex.
Hsu N; Young LS; Bermudez LE
Infect Immun; 1995 Feb; 63(2):528-33. PubMed ID: 7822018
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
3. Potential role of cytokines in disseminated mycobacterial infections.
Bermudez LE
Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S29-33. PubMed ID: 7875149
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.
Bermudez LE; Wu M; Young LS
Infect Immun; 1995 Oct; 63(10):4099-104. PubMed ID: 7558325
[TBL] [Abstract][Full Text] [Related]
5. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.
Bermudez LE; Young LS
J Leukoc Biol; 1990 Jul; 48(1):67-73. PubMed ID: 2113563
[TBL] [Abstract][Full Text] [Related]
6. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
[TBL] [Abstract][Full Text] [Related]
7. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.
Suzuki K; Lee WJ; Hashimoto T; Tanaka E; Murayama T; Amitani R; Yamamoto K; Kuze F
Clin Exp Immunol; 1994 Oct; 98(1):169-73. PubMed ID: 7923877
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of bovine macrophages to Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium.
Weiss DJ; Evanson OA; Moritz A; Deng MQ; Abrahamsen MS
Infect Immun; 2002 Oct; 70(10):5556-61. PubMed ID: 12228282
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
Tomioka H; Sato K; Maw WW; Saito H
J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
[TBL] [Abstract][Full Text] [Related]
10. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
Tomioka H; Sato K; Shimizu T; Sano C; Akaki T; Saito H; Fujii K; Hidaka T
Antimicrob Agents Chemother; 1997 Feb; 41(2):357-62. PubMed ID: 9021192
[TBL] [Abstract][Full Text] [Related]
11. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
Tomioka H; Maw WW; Sato K; Saito H
Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
[TBL] [Abstract][Full Text] [Related]
12. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
Bermudez LE
J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
[TBL] [Abstract][Full Text] [Related]
13. 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF.
Bermudez LE; Young LS; Gupta S
Cell Immunol; 1990 May; 127(2):432-41. PubMed ID: 2183943
[TBL] [Abstract][Full Text] [Related]
14. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.
Champsi J; Young LS; Bermudez LE
Immunology; 1995 Apr; 84(4):549-54. PubMed ID: 7790028
[TBL] [Abstract][Full Text] [Related]
15. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.
Bermudez LE
Clin Exp Immunol; 1993 Feb; 91(2):277-81. PubMed ID: 8428392
[TBL] [Abstract][Full Text] [Related]
16. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens.
Black CM; Bermudez LE; Young LS; Remington JS
J Exp Med; 1990 Sep; 172(3):977-80. PubMed ID: 2117640
[TBL] [Abstract][Full Text] [Related]
17. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.
Bermudez LE; Martinelli J; Petrofsky M; Kolonoski P; Young LS
J Infect Dis; 1994 Mar; 169(3):575-80. PubMed ID: 8158029
[TBL] [Abstract][Full Text] [Related]
18. Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.
Bermudez LE; Petrofsky M; Stevens P
Immunology; 1998 Jul; 94(3):297-303. PubMed ID: 9767410
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
Denis M
J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
[TBL] [Abstract][Full Text] [Related]
20. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).
Sato K; Akaki T; Tomioka H
Clin Exp Immunol; 1998 Apr; 112(1):63-8. PubMed ID: 9566791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
